Application 210329
- Type
- ANDA
- Sponsor
- JUBILANT GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210329-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210329-001 | AB1 |
| A210329-002 | AB1 |
| A210329-003 | AB1 |
| A210329-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210329-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | Aurobindo Pharma Limited | a0ecc7cf-20dd-485a-b4dd-1bbc587280a7 | 2024-06-03 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aurobindo Pharma Limited | 0345b81b-f946-4dd6-b49d-2a2bdd4c49c9 | 2024-05-24 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | a73b0e6f-09fc-42d6-a678-1409ce746bd1 | 2024-05-17 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Asclemed USA, Inc. | 101f44e4-669c-4e3d-843a-a27157750f9c | 2024-05-07 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals,Inc. | 17947ccd-6f0e-d4cd-e063-6294a90a108a | 2024-05-03 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 6fd94914-0c9d-4268-8ed8-3c2690707a5d | 2024-04-05 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | a3190ceb-fb3f-45f7-a12d-4c333edaadc6 | 2024-04-03 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | a930511d-110e-4d2e-a4ca-df712f968b2d | 2024-04-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 78b6659c-3a46-4998-9151-1a53afd83375 | 2024-04-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | d1dd9d05-e9d3-49ea-aeda-047536a27037 | 2024-03-28 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | 13a107ba-cbbd-7760-e063-6394a90a1ee8 | 2024-03-14 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Unichem Pharmaceuticals (USA), Inc. | a7b3937e-ff03-436a-a5d4-92a4771034b6 | 2024-01-31 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | A-S Medication Solutions | b9d71483-861b-465b-846b-d7bfd6cbac11 | 2023-12-26 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | A-S Medication Solutions | c1c8feb4-a85a-4f39-8c44-bc9cd77226f4 | 2023-12-21 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Lupin Pharmaceuticals, Inc. | efa03afa-c412-4b31-bf26-7c3a6f7311af | 2023-12-14 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Camber Pharmaceuticals, Inc. | dc0a6a03-5ef1-4507-b888-5b559653c3e9 | 2023-11-27 | Boxed warning, Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NorthStar RxLLC | 594acc15-a5bc-43b5-9659-a864b2c46eea | 2023-11-10 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Zydus Pharmaceuticals USA Inc. | cfe43ab8-8721-4db8-8810-f0072cf8f4d3 | 2023-11-08 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 7dfb450b-4d39-40e7-b115-9a96023052a0 | 2023-11-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | 51f87c9b-038c-4793-b0d5-5359ae231074 | 2023-10-31 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.